Norwegian Medicines Agency

Recent papers from Norwegian Medicines Agency

1. Strengthening pharmacovigilance systems through Africa-Europe collaboration: Insights from a regulatory roundtable discussionOpen Research Europe · 2026
2. Proactive Resilience Programmes for Improving Resilience and Psychological Adaptation in Employees in High-Risk Occupations: A Systematic ReviewCampbell Systematic Reviews · 2026
3. Perioperative propranolol during robotic‐assisted radical prostatectomy: A randomised, double‐blind, placebo‐controlled, pilot trial (PeP‐RALP)BJUI Compass · 2026
4. Do consumers and healthcare professionals report the same adverse event differently? A paired analysis of duplicate vaccine safety reports in NorwayBritish Journal of Clinical Pharmacology · 2026
5. Covert administration of drugs in drug facilitated sexual assault: A prospective observational study from Oslo, NorwayForensic Science International Reports · 2026
6. Second regulatory workshop on utilising in silico models to expedite vaccine development, testing, and lifecycle management - an expert meeting reportVaccine · 2026
7. Using PEth and AUDIT-4 to Detect Harmful Alcohol Use Among People with Severe Substance UseSubstance Use & Misuse · 2026
8. Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive AnalysisPharmaceutical Medicine · 2026
9. Physiologically Based Biopharmaceutics Modelling—Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportPharmaceutics · 2026
10. Myocarditis after COVID-19 mRNA vaccination in Norway: a nationwide validation studyOpen Heart · 2026
11. "Why should I pay for this vaccine?" - Norwegian adolescents views on meningococcal vaccination.2026
12. Transfusion reactions after whole blood transfusion in Norway, 2021–2024: A report from the Norwegian Hemovigilance programTransfusion · 2026
13. Characteristics, treatment and survival of patients with chondrosarcoma in five European countries: a DARWIN EU® cohort studyActa Oncologica · 2026
14. A computational framework for mesoscale modelling of concrete with application to ballistic impactEuropean Journal of Mechanics - A/Solids · 2026
15. Challenges and Potential Solutions to Advance Global Cancer Drug DevelopmentTherapeutic Innovation & Regulatory Science · 2026
16. Risk factors for bark stripping damage on Norway spruce by red deerWildlife Biology · 2026
17. Normal cardiac function but discrete late gadolinium enhancement findings after COVID-19 vaccine-associated myocarditis - a nationwide long-term follow-up studyEuropean Heart Journal · 2025
18. Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023Eurosurveillance · 2025
19. New pathways with high-sensitivity cardiac troponin testing at the point of care in the ambulance and primary careEuropean Heart Journal Acute Cardiovascular Care · 2025
20. Changes in clinical features and severity in patients presenting to European emergency departments with acute cannabis toxicity over the 10‐year period from 2013 to 2022Addiction · 2025